Retraction notice to "Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms" [Biomedicine & Pharmacotherapy 146 (2022) 112442] - 04/06/26
Doi : 10.1016/j.biopha.2026.119599
Hasan Slika a, Hadi Mansour a, Nadine Wehbe b, Suzanne A. Nasser c, Rabah Iratni d, Gheyath Nasrallah e, Abdullah Shaito f, Tarek Ghaddar g, Firas Kobeissy h, Ali H. Eid i, j, ⁎
a Department of Pharmacology and Toxicology, American University of Beirut, P.O. Box 11-0236, Beirut, Lebanon
b Department of Biology, American University of Beirut, P.O. Box 11-0236, Beirut, Lebanon
c Department of Pharmacology and Therapeutics, Beirut Arab University, P.O. Box 11-5020, Beirut, Lebanon
d Department of Biology, College of Science, United Arab Emirates University, P.O. Box 15551, Al-Ain, United Arab Emirates
e Department of Biomedical Sciences, College of Health Sciences, Qatar University, P.O. Box: 2713, Doha, Qatar
f Biomedical Research Center, Qatar University, P.O. Box: 2713, Doha, Qatar
g Department of Chemistry, American University of Beirut, P.O. Box 11-0236, Beirut, Lebanon
h Department of Biochemistry and Molecular Genetics, American University of Beirut, P.O. Box: 11-0236, Beirut, Lebanon
i Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar
j Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar
⁎ Corresponding author.
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Thursday 04 June 2026
Le texte complet de cet article est disponible en PDF.
© 2026
Publié par Elsevier Masson SAS.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?